D & K Healthcare (NASDAQ:DKHR)
Historical Stock Chart
From Jun 2019 to Jun 2024
The Board of Directors of D&K Healthcare Resources, Inc.
(Nasdaq: DKHR) today declared the company's 18th consecutive regular
quarterly cash dividend. The dividend of $0.015 per share of common
stock, is payable on June 9, 2005 to shareholders of record on May 26,
2005.
D&K Healthcare Resources, Inc., which had fiscal 2004 sales of
$2.5 billion, is a full-service wholesale distributor of branded and
generic pharmaceuticals and over-the-counter health and beauty aid
products. Headquartered in St. Louis, D&K serves three classes of
customers from eight distribution centers: independent and regional
pharmacies with locations in one or more of 27 states, primarily in
the Midwest, Upper Midwest and South; national accounts that operate
locations in multiple regions of the United States; and other
healthcare providers including hospitals, alternate-site care
providers, and pharmacy benefit management companies in its primary
distribution area. D&K also offers a number of proprietary information
systems, marketing and business management solutions, and owns
Pharmaceutical Buyers, Inc., a leading alternate-site group purchasing
service located in Broomfield, CO. More information can be found at
www.dkhealthcare.com.
This press release contains forward-looking statements within the
meaning of the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements are
inherently subject to risks and uncertainties. The company's actual
results could differ materially from those currently anticipated due
to a number of factors, including without limitation, the competitive
nature of the wholesale pharmaceutical distribution industry with many
competitors having substantially greater resources than D&K
Healthcare, the company's ability to maintain or improve its operating
margins with the industry's competitive pricing pressures, the
company's customers and suppliers generally having the right to
terminate or reduce their purchases or shipments on relatively short
notice, changes in the company's prime vendor status with cooperative
purchasing groups, the availability of investment purchasing
opportunities, the company's ability to complete and integrate
acquisitions successfully, the changing business and regulatory
environment of the healthcare industry in which the company operates,
including manufacturers' pricing or distribution policies or
practices, the loss of one or more key suppliers for which alternative
sources may not be available, changes in private and governmental
reimbursement or in the delivery systems for healthcare products,
changes in interest rates, and other factors set forth in reports and
other documents filed by D&K Healthcare with the Securities and
Exchange Commission from time to time. The reader should not place
undue reliance on forward-looking statements, which speak only as of
the date they are made. D&K Healthcare undertakes no obligation to
publicly update or revise any forward-looking statements.